 |
 |
|
|
RESÚMENES AGOSTO 2004 |
Basic Neuroscience
& Pharmacology
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Richard Hodgson, Susan E. Smith, Richard C. Strange,
Anthony A. Fryer
Psychiatric Bulletin
(2004) 28: 298-300
Effect
of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states
Kyung-Sang
Yu MD, Joo-Youn Cho, In-Jin
Jang, Kyoung-Seop Hong, Jae-Yong
Chung, Jung-Ryul Kim, Hyeong-Seok
Lim, Dal-Seok Oh, So-Young Yi, Kwang-Hyeon
Liu, Jae-Gook Shin and Sang-Goo
Shin
Clinical Pharmacology &
Therapeutics.Volume 76, Issue 2 , August 2004, Pages
104-112
The
somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter
systems
Albert Adell and Francesc Artigas
Neuroscience
& Biobehavioral Reviews. Volume 28, Issue 4 , July 2004, Pages 415-431
-Adrenergic modulation of emotional
memory-evoked human amygdala and hippocampal
responses
B. A. Strange and R. J. Dolan
PNAS
| August 3, 2004 | vol. 101 | no. 31 | 11454-11458
Negative
correlation between right prefrontal activity during response inhibition and
impulsiveness: A fMRI study
Sh. Asahi, Y. Okamoto,
G. Okada, Sh. Yamawaki
and N. Yokota
European Archives of Psychiatry and Clinical
Neuroscience 2004; Volume 254, Number
4: 245 - 251
Music
improves dopaminergic neurotransmission:
demonstration based on the effect of music on blood pressure regulation
Denetsu Sutoo
and Kayo Akiyama
Brain Research. Volume 1016, Issue 2, 6 August 2004, Pages 255-262
Naomi I. Eisenberger and Matthew D. Lieberman
Trends in Cognitive Sciences. Volume 8, Issue 7, July 2004, Pages 294-300
L. A. M. Aerden, F. A. G. H. Kessels, B. P. F. Rutten, J. Lodder and H. W.
M. Steinbusch
Neuroscience Letters. Volume 367, Issue 1, 26 August 2004, Pages 76-78
Enhanced
stimulant and metabolic effects of combined ephedrine and caffeine
Christine
A. Haller, Peyton Jacob, III and Neal L. Benowitz
Clinical Pharmacology &
Therapeutics. Volume 75, Issue 4,
April 2004, Pages 259-273
Christer Tannergren,
Helena Engman, Lars Knutson, Mikael
Hedeland, Ulf Bondesson and
Hans Lennernäs
Clinical Pharmacology &
Therapeutics. Volume 75, Issue 4,
April 2004, Pages 298-309
Clinical Pharmacokinetics of Levetiracetam.
Patsalos PN.
Clin Pharmacokinet. 2004;43(11):707-724.
Human
genetics of plasma dopamine B-hydroxylase activity:
applications to research in psychiatry and neurology
J. F. Cubells and C. P. Zabetian
Psychopharmacology 2004; Volume 174, Number
4: 463 - 476
Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities
Martin Sarter and John P. Bruno
Neurobiology of Aging. Volume 25, Issue 9, October 2004, Pages 1127-1139
Relations
between emotion and conscious recollection of true and false autobiographical
memories: an investigation using lorazepam as a
pharmacological tool
Elodie Pernot-Marino,
Jean-Marie Danion and Guy Hedelin
Psychopharmacology 2004; Volume 175, Number 1: 60
- 67
Tim Karl, Shu Lin, Christoph
Schwarzer, Amanda Sainsbury, Michelle Couzens, Walter Wittmann, Dana Boey,
Stephan von Hörsten, and Herbert Herzog
Proc. Natl. Acad. Sci. USA, August 2004
Brain-Derived
Tumor Necrosis Factor-
and Its Involvement in Noradrenergic Neuron Functioning Involved in the
Mechanism of Action of an Antidepressant
Jessica L. Reynolds, Tracey A. Ignatowski,
Reeteka Sud, and Robert N. Spengler
Role of Neuroactive
Steroid Allopregnanolone in Antipsychotic-like Action
of Olanzapine in Rodents
Rajesh R Ugale,
Khemraj Hirani, Micaela Morelli and Chandrabhan T Chopde
Neuropsychopharmacology (2004) 29, 1597-1609
Prepulse
Inhibition Deficits in GAD65 Knockout Mice and the Effect of Antipsychotic
Treatment
Scott A Heldt,
Amanda Green and Kerry J Ressler
Neuropsychopharmacology (2004) 29, 1610-1619
Comparison of the Effects of Citalopram and Escitalopram on
5-Ht-Mediated Neuroendocrine Responses
Haitham S Nadeem, Mary-Jane
Attenburrow and Philip J Cowen
Neuropsychopharmacology (2004) 29, 1699-1703
Y1 receptors regulate aggressive behavior by
modulating serotonin pathways
Tim Karl, Shu Lin, Christoph
Schwarzer, Amanda Sainsbury, Michelle Couzens, Walter Wittmann, Dana Boey,
Stephan von Hörsten and Herbert Herzog
PNAS | August 24, 2004 |
vol. 101 | no. 34 | 12742-12747
Effects of fluoxetine on
dopamine D2 receptors in the human brain: a positron emission tomography study
with 11Craclopride.
Penttil J, Kajander
J, Aalto S, Hirvonen J, Ngren K, Ilonen T, Syvlahti E, Hietala J.
Int J Neuropsychopharmacol.
2004 Jul 26;:1-9. [Epub
ahead of print]
Effects
of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous
cycle and uterine weight in female rats
M. J.
Fell, J. C. Neill and K. M. Marshall
European
Neuropsychopharmacology. Volume 14, Issue 5,
October 2004, Pages 385-392